Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating acute mastitis and preparation method thereof

A technology for acute mastitis and composition, applied in the field of pharmaceutical composition for treating acute mastitis and its preparation, can solve the problems of affecting infant breastfeeding, unfavorable breastfeeding women, and insignificant therapeutic effect, so as to avoid taking medicine Pain, convenient treatment, remarkable effect of treatment

Inactive Publication Date: 2018-05-04
尹心刚
View PDF8 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there are many drugs for the treatment of acute mastitis, but most of them are taken internally. Since many patients with mastitis are lactating women, oral drugs will directly affect the breastfeeding of the baby, and the therapeutic effect is not significant, so many oral drugs Not good for breastfeeding women

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating acute mastitis and preparation method thereof
  • Pharmaceutical composition for treating acute mastitis and preparation method thereof
  • Pharmaceutical composition for treating acute mastitis and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0098] Example 1 Granules for external use

[0099] Blue Buzheng 120g Wangbuliuxing 40g Motherwort 10g

[0100] Horse Chestnut 100g, Gecko 100g, Dew Honeycomb 40g.

[0101] Take 1 / 3 of the blue cloth to be superfinely pulverized to obtain superfine powder, after superfine pulverization, the particle size of more than 85% of the micropowder is not more than 8 microns; take 1 / 2 of Aescin and 1 / 2 of gecko respectively with high pressure Pulverize into a fine powder; wash the remaining blue cloth, add 8 times the amount of water to soak for 30 minutes, then decoct, decoct for 2 hours for the first time, and filter to obtain the filtrate; use 4 times the amount of medicinal residue decoct in water for 1.5 hours, filter to obtain the filtrate, combine the two filtrates, filter, centrifuge the filtrate, centrifuge at 3000rpm, centrifuge for 4 minutes, separate the supernatant, evaporate to dryness in a water bath and concentrate to extract A of 1.25-1.30; Aesculus aesculus was soa...

Embodiment 2

[0102] Embodiment 2 pills for external use

[0103] Blue cloth is 80g Wangbuliuxing 55g Motherwort 7g

[0104] Horse Chestnut 95g, Gecko 55g, Dew Honeycomb 55g.

[0105] Take 1 / 3 of the blue cloth to be superfinely pulverized to obtain superfine powder, after superfine pulverization, the particle size of more than 85% of the micropowder is not more than 8 microns; take 1 / 2 of Aescin and 1 / 2 of gecko respectively with high pressure Pulverize into a fine powder; wash the remaining blue cloth, add 8 times the amount of water to soak for 30 minutes, then decoct, decoct for 2 hours for the first time, and filter to obtain the filtrate; use 4 times the amount of medicinal residue decoct in water for 1.5 hours, filter to obtain the filtrate, combine the two filtrates, filter, centrifuge the filtrate, centrifuge at 3000rpm, centrifuge for 4 minutes, separate the supernatant, evaporate to dryness in a water bath and concentrate to extract A of 1.25-1.30; Aesculus aesculus was soake...

Embodiment 3

[0106] Embodiment 3 ointment

[0107] Blue cloth is 160g Wangbuliuxing 25g Motherwort 13g

[0108] Aescin 55g, gecko 95g, honeycomb 25g.

[0109] The above-mentioned drugs are added with conventional auxiliary materials according to the conventional process to make ointment. Apply to the affected area morning and evening and rub in.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating acute mastitis and a preparation method thereof. The composition is prepared from six raw medicinal materials of herba gei, semen vaccariae, herba leonuri, rhizoma paris polyphyllae, gecko japonicus and nidus vespae. The pharmaceutical composition disclosed by the invention has effects of clearing heat, removing toxicity, regulatingqi to alleviate pain, promoting blood circulation and removing stasis and has obvious effects of treating breast lump pain, hyperpyrexia, cold intolerance and the like caused by the acute mastitis. The pharmaceutical composition disclosed by the invention is external-used medicine, so that the pharmaceutical composition is not only convenient to use, but also avoids the pain of taking medicine; furthermore, the pharmaceutical composition has an obvious curative effect and can achieve a curing effect in a short time.

Description

technical field [0001] The invention relates to a composition, in particular to a pharmaceutical composition for treating acute mastitis and a preparation method thereof. Background technique [0002] Acute mastitis is a common disease in women. According to different causes, it can be divided into acute suppurative mastitis, paraareolar fistula, plasma cell mastitis, etc. The most common acute suppurative mastitis is used here as a statement. Acute suppurative mastitis often occurs during lactation, especially within 1 to 2 months after delivery in primiparous women, so it is also called acute suppurative mastitis during lactation or puerperium, and it is called "milk carbuncle" in traditional Chinese medicine. The incidence of acute mastitis in primiparous women is as high as 2% to 4%, which is twice as high as that in multiparous women. Milk stasis is accompanied by bacterial infection and presents as acute inflammation, redness, swelling and pain, chills and high fever....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/896A61K9/16A61K9/20A61P15/14A61K35/64A61K35/583
CPCA61K36/896A61K9/0041A61K9/1652A61K9/2054A61K35/583A61K35/63A61K36/36A61K36/533A61K36/74A61K2236/53A61K2236/51A61K2236/39A61K2236/331A61K2300/00
Inventor 尹心刚田孟泽尹心杨
Owner 尹心刚
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com